David Hung is listed as a director on 1 SEC Form D filing by 1 issuer in Apr 2009: Acer Therapeutics Inc. (Newton, MA — biotechnology — 2009; $4.08M reported sold to 28 investors).
What this means One deal on file with the SEC, filed Apr 2009. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
The issuer belongs to the sponsor group Acer Therapeutics (2 issuers, $17.2M reported sold, 2009–2022).
What this means A sponsor group is one team that sets up a new company for each deal. Acer Therapeutics has 2 companies on file and $17.2M reported sold in total — the group page shows the whole track record in one place.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 1 public filing for David Hung and found 4 differences: No amendment in the last 12 months on an offering that may still be open; Same name, different state: "DAVID HUNG" (G2) is a separate record; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.